Immunomic Therapeutics, Inc.

BioTech/Drugs - Rockville, MD, US

Immunomic Therapeutics, Inc. Details

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform. This investigational technology has the potential to alter how we use immunotherapy for a number of diseases, including cancer, allergy and infectious diseases.

Immunomic Therapeutics, Inc. logo, Immunomic Therapeutics, Inc. contact details
Website: immunomix.com
Employees: 50 - 99
HQ: 301-968-3501
Location: Rockville, MD, US
Revenue: 5 - 10 Million
DNA Vaccines LAMP Technology Allergy Oncology Animal Health Infectious Diseases B2B Biotech SaaS Commercial Physical Research Biotechnology
Immunomic Therapeutics, Inc. Technologies
Email Providers

Outlook

Load Balancers

Apache

Fonts

Google Font API

Other

Mobile Friendly

CSS and JavaScript Libraries

Bootstrap Framework

View All Technologies Used At Immunomic Therapeutics, Inc.

Contacting Immunomic Therapeutics, Inc.: Connect with Executives and Employees

Get in Touch with Immunomic Therapeutics, Inc. Executives and Employees

Connecting with Immunomic Therapeutics, Inc.'s Executives and Workforce

Accessing Contact Information for Immunomic Therapeutics, Inc. Executives

Connecting with Immunomic Therapeutics, Inc.: Reach Out to Their Team

Discover How to Contact Immunomic Therapeutics, Inc. Executives and Staff

Looking to connect with Immunomic Therapeutics, Inc. executives or employees?

Seeking to Get in Touch with Immunomic Therapeutics, Inc. Executives or Staff?

Want to Reach Out to Immunomic Therapeutics, Inc. Executives or Team Members?

In Search of Contact Details for Immunomic Therapeutics, Inc. Professionals?

Connecting with Immunomic Therapeutics, Inc.: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z